Read + Share
Lawrence L. Studies evaluate de-escalation of treatment for certain patients with breast
cancer: No significant differences were found in overall survival rates between
the group receiving chemotherapy plus hormonotherapy and the group receiving
hormonotherapy al Cancer 2025;131:e70135.
PMID: 41332129
|
 |
|
